Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors
NCT ID: NCT00933296
Last Updated: 2017-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2009-07-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura
NCT01610830
Evaluation of Peripheral Neutrophils in Antisynthetase Syndrome
NCT05691725
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
NCT06004817
Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis (RMN-SARCURINES)
NCT05181930
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A Patients with the Schnitzler syndrome
Patients with the Schnitzler syndrome
No interventions assigned to this group
B Control subjects:
B1 healthy B2 other diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Lipsker, Pr
Role: PRINCIPAL_INVESTIGATOR
HUS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Besançon Service de Dermatologie
Besançon, , France
Service de DermatologieCHU Morvan5 avenue Foch
Brest, , France
Centre Hospitalier Général Bd Yves du Manoir
Dax, , France
Service de Rhumatologie Centre Hospitalier du Mans
Le Mans, , France
Service de Médecine Interne Hôpital Claude-Huriez
Lille, , France
Service de DermatologieHôtel Dieu
Lyon, , France
Service médecine interne et thérapeutique Hôpital sainte marguerite
Marseille, , France
Service de Dermatologie Hôpital Saint Eloi 80 avenue A Fliche
Montpellier, , France
Service de dermatologie CHU Hôtel Dieu1 place Alexis Ricordeau
Nantes, , France
Unité de médecine interne Centre Hospitalier G. Renon
Niort, , France
Service d'immuno-hématologie Hôpital St-Louis 1 av Claude Vellefaux
Paris, , France
Service de médecine interne Hôpital Tenon4, rue de la Chine
Paris, , France
Service de dermatologieCHU GUERIN2 rue de la Milétrie
Poitiers, , France
BOYE Thierry
Toulon, , France
Service de médecine interne-néphrologie Centre Hospitalier Valenciennes
Valenciennes, , France
Azienda Ospedaliero Universitaria Policlinico
Bari, , Italy
Clinica DermatologicaUnivesité de GênesVialle Benedetto
Genova, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.